All In MedTech

Device Trial Radar · NCT01073566

Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections

The Effects of Finesse on Glycemic Control in Adults With Diabetes Using MDI: Finesse vs. Pen or Syringe and Vial as Bolus Prandial Insulin Device

Last checked: Nov 20, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

38

Actual

Start

Jan 2010

Primary completion

Jul 2010

Study completion Jul 2010

Sponsor

Lead sponsor
Calibra Medical, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Nancy Bohannon, MD, Med. Corp.; Henry Ford Health System; Northwestern University; University of Texas Southwestern Medical Center; International Diabetes Center at Park Nicollet
First posted
Feb 23, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate that Finesse, for prandial insulin bolusing when used in conjunction with basal insulin, achieves equivalent glycemic control when compared to multiple daily injections and to evaluate its preference.

Conditions

  • Diabetes Mellitus

Interventions

  • FinesseDevice

    Finesse Insulin Delivery Patch

  • Pen/Syringe (Usual injection device)Device

    Pen/Syringe

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Daily Blood GlucoseTime frame: 6 weeks

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • California Pacific Medical Center

    San Francisco, California

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.